UGT1A1功能缺失多态性导致12岁男性静脉吗啡后中枢性呼吸暂停延长
本文报告一例无睡眠呼吸暂停史的12岁男性骨折患者,在静脉吗啡镇痛和氯胺酮镇静后反复出现中枢性呼吸暂停和低氧血症。药物基因组学检测发现其UGT1A1 rs887829位点T等位基因纯合,为功能缺失变异,导致吗啡代谢受损,可能增加呼吸抑制风险。
要点
- 静脉吗啡后出现反复延长中枢性呼吸暂停和低氧血症,提示UGT1A1功能缺失变异可能增加呼吸抑制风险。
- 对于标准剂量吗啡后出现过度镇静或呼吸抑制的患者,尤其有家族史或既往史支持代谢缺陷时,可考虑基因检测。
- 用药前应询问患者及家族既往阿片类药物使用情况,以预判潜在不良反应。
核心结论
- UGT1A1 rs887829 T等位基因纯合的功能缺失变异可能导致吗啡代谢受损,增加呼吸抑制风险。
研究设计与样本
- 病例报告:一例12岁男性骨折患者,静脉吗啡镇痛和氯胺酮镇静后出现反复延长中枢性呼吸暂停和低氧血症。
主要发现
- 患者无睡眠呼吸暂停史,用药后反复出现中枢性呼吸暂停和低氧血症。
- 药物基因组学检测显示患者为UGT1A1 rs887829位点T等位基因纯合,为功能缺失变异。
临床怎么用
- 用药前应询问患者及家族既往阿片类药物使用情况。
- 对标准剂量吗啡后出现过度镇静或呼吸抑制者,尤其有家族史或既往史支持代谢缺陷时,可考虑基因检测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ADVERSE EVENT: Repeated and prolonged episodes of central apnoea and hypoxia after receiving intravenous morphine for analgesia and ketamine for sedation. DRUG IMPLICATED: Intravenous morphine sulfate. THE PATIENT: Previously healthy 12-year-old male with no history of sleep apnoea who presented with distal tibia and fibula fracture. EVIDENCE THAT LINKS DRUG TO EVENT: Pharmacogenomic testing revealed that the patient was homozygous for the T allele at the rs887829 SNP in UGT1A1, an enzyme involved in the metabolism of morphine. This polymorphism is a loss-of-function variant, leading to impaired metabolism of morphine. MECHANISM: Morphine is metabolized by UDP-glucuronosyltransferase (UGT)-2B7 and UGT1A1 to form its major metabolites morphine-3-glucuronide (M3G) and morphine-6-glucuronide (M6G). Our patient was a poor metabolizer through UGT1A1, likely leading to increased respiratory depression as morphine has greater respiratory depressant effects compared to its metabolites. IMPLICATIONS: When appropriate, physicians should enquire about prior receipt of opioids, in both the patient and family, to be better prepared for potential adverse reactions. In the patient with excessive sedation or respiratory depression to standard doses of morphine, genetic testing may be warranted, especially if there is a family or past history that supports a metabolic defect in morphine metabolism and/or excretion.
引用
- Toce MS, Kim H, Chung S, et al. Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism. Br J Clin Pharmacol. 2018. PMID: 30421550. doi:10.1111/bcp.13779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。